KR880000191B1 - 급성방사선 증후군 발현억제 및 패혈증 발현억제 조성물 - Google Patents

급성방사선 증후군 발현억제 및 패혈증 발현억제 조성물 Download PDF

Info

Publication number
KR880000191B1
KR880000191B1 KR1019850004992A KR850004992A KR880000191B1 KR 880000191 B1 KR880000191 B1 KR 880000191B1 KR 1019850004992 A KR1019850004992 A KR 1019850004992A KR 850004992 A KR850004992 A KR 850004992A KR 880000191 B1 KR880000191 B1 KR 880000191B1
Authority
KR
South Korea
Prior art keywords
composition
warm
inhibiting
rde
acute radiation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
KR1019850004992A
Other languages
English (en)
Korean (ko)
Other versions
KR860000867A (ko
Inventor
어니스트 리비 에드가
Original Assignee
리비 이뮤노켐 리써어치 인코포레이티드
원본미기재
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 리비 이뮤노켐 리써어치 인코포레이티드, 원본미기재 filed Critical 리비 이뮤노켐 리써어치 인코포레이티드
Publication of KR860000867A publication Critical patent/KR860000867A/ko
Application granted granted Critical
Publication of KR880000191B1 publication Critical patent/KR880000191B1/ko
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
KR1019850004992A 1984-07-12 1985-07-12 급성방사선 증후군 발현억제 및 패혈증 발현억제 조성물 Expired KR880000191B1 (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/630,013 US4629722A (en) 1984-07-12 1984-07-12 Method of inhibiting the onset of acute radiation syndrome
US630013 1984-07-12

Publications (2)

Publication Number Publication Date
KR860000867A KR860000867A (ko) 1986-02-20
KR880000191B1 true KR880000191B1 (ko) 1988-03-12

Family

ID=24525404

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019850004992A Expired KR880000191B1 (ko) 1984-07-12 1985-07-12 급성방사선 증후군 발현억제 및 패혈증 발현억제 조성물

Country Status (14)

Country Link
US (1) US4629722A (enExample)
JP (1) JPS6193123A (enExample)
KR (1) KR880000191B1 (enExample)
AU (1) AU556971B2 (enExample)
BE (1) BE902875A (enExample)
CH (1) CH665355A5 (enExample)
DE (2) DE3524992A1 (enExample)
FR (1) FR2567403A1 (enExample)
GB (1) GB2161381B (enExample)
IL (1) IL75789A (enExample)
IT (1) IT1214671B (enExample)
NL (1) NL8501995A (enExample)
NZ (1) NZ212691A (enExample)
ZA (1) ZA855243B (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019009522A1 (ko) * 2017-07-06 2019-01-10 이보미 안경알 자판기 서비스 제공 방법

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4866034A (en) * 1982-05-26 1989-09-12 Ribi Immunochem Research Inc. Refined detoxified endotoxin
US5354782A (en) * 1991-01-17 1994-10-11 Merrell Dow Pharmaceuticals Inc. Polyamine phenols as radioprotective agents
AU660325B2 (en) * 1991-10-11 1995-06-22 Eisai Co. Ltd. Anti-endotoxin compounds and related molecules and methods
US5530113A (en) * 1991-10-11 1996-06-25 Eisai Co., Ltd. Anti-endotoxin compounds
US6218166B1 (en) 1994-12-09 2001-04-17 John Wayne Cancer Institute Adjuvant incorporation into antigen carrying cells: compositions and methods
US20090181078A1 (en) * 2006-09-26 2009-07-16 Infectious Disease Research Institute Vaccine composition containing synthetic adjuvant
US8273361B2 (en) 2006-09-26 2012-09-25 Infectious Disease Research Institute Vaccine composition containing synthetic adjuvant
LT2437753T (lt) 2009-06-05 2016-12-12 Infectious Disease Research Institute Sintetiniai gliukopiranozillipidų adjuvantai ir juos turinčios vakcinų kompozicijos
WO2012141984A1 (en) 2011-04-08 2012-10-18 Immune Design Corp. Immunogenic compositions and methods of using the compositions for inducing humoral and cellular immune responses
LT2850431T (lt) 2012-05-16 2018-06-25 Immune Design Corp. Vakcinos, skirtos hsv-2
KR102039520B1 (ko) 2013-04-18 2019-11-01 이뮨 디자인 코포레이션 암 치료에 이용하기 위한 gla 단일요법
US9463198B2 (en) 2013-06-04 2016-10-11 Infectious Disease Research Institute Compositions and methods for reducing or preventing metastasis
AU2015317771A1 (en) * 2014-09-16 2017-04-06 Bioincept, Llc Compositions and methods for treating acute radiation syndrome
EP3341739A4 (en) 2015-08-28 2019-07-10 BioIncept LLC MUTATED PEPTIDES AND METHOD FOR TREATING SUBJECTS THEREWITH
CA2996874A1 (en) 2015-08-28 2017-03-09 Bioincept, Llc Compositions and methods for the treatment of neurodamage

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1188519A (en) * 1966-10-27 1970-04-15 Wellcome Found Method for the Purification of Lipopolysaccharides
US4435386A (en) * 1982-05-26 1984-03-06 Ribi Immunochem Research, Inc. Refined detoxified endotoxin product
US4436728A (en) * 1982-05-26 1984-03-13 Ribi Immunochem Research, Inc. Refined detoxified endotoxin product
CA1225592A (en) * 1983-08-26 1987-08-18 Ribi Immunochem Research Inc. Refined detoxified endotoxin

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019009522A1 (ko) * 2017-07-06 2019-01-10 이보미 안경알 자판기 서비스 제공 방법

Also Published As

Publication number Publication date
DE3546592C2 (enExample) 1988-06-01
BE902875A (fr) 1985-11-04
GB2161381B (en) 1988-01-13
AU556971B2 (en) 1986-11-27
ZA855243B (en) 1986-02-26
IT1214671B (it) 1990-01-18
IL75789A0 (en) 1985-11-29
IT8548347A0 (it) 1985-07-12
DE3524992A1 (de) 1986-01-16
FR2567403A1 (fr) 1986-01-17
KR860000867A (ko) 1986-02-20
DE3524992C2 (enExample) 1988-05-11
GB2161381A (en) 1986-01-15
CH665355A5 (de) 1988-05-13
IL75789A (en) 1990-04-29
AU4475885A (en) 1986-01-16
JPS6234733B2 (enExample) 1987-07-28
JPS6193123A (ja) 1986-05-12
NZ212691A (en) 1988-02-12
US4629722A (en) 1986-12-16
NL8501995A (nl) 1986-02-03
GB8517545D0 (en) 1985-08-14

Similar Documents

Publication Publication Date Title
KR880000191B1 (ko) 급성방사선 증후군 발현억제 및 패혈증 발현억제 조성물
Sultzer et al. PPD tuberculin—a B-cell mitogen
EP0172721A2 (en) Use of phlorizin or its derivatives in combination with a chemotherapeutic agent for the treatment of cancer
Peterson et al. Prolonged maintained remissions of adult acute non-lymphocytic leukaemia
Hattori et al. Clinicopathological features of chronic inflammatory demyelinating polyradiculoneuropathy in childhood
Greco et al. Treatment of oat cell carcinoma of the lung: complete remissions, acceptable complications, and improved survival.
SK2697A3 (en) Use of muramyl peptide compounds and pharmaceutical composition
Joseph et al. Recurrence of nonneoplastic thymus after thymectomy for myasthenia gravis: report of two cases
EP0776211A1 (en) 2-halo-2'-deoxyadenosine treatment for histiocytosis
Gunther et al. Oral trimethoprim as follow-up treatment of meningitis caused by Listeria monocytogenes
Soble et al. Fatal radiation pneumonia following subclinical busulfin injury
PT94517A (pt) Processco para a preparacao de derivados de muramil-dipeptideos
Carpenter et al. Chemotherapy of murine leprosy
Vogler et al. A randomized clinical trial of remission induction, consolidation, and chemo-immunotherapy maintenance in adult acute myeloblastic leukemia
Harvey et al. Peripheral nervous system demyelination from systemic transfer of experimental allergic neuritis serum
CN119385998B (zh) N-乙酰甘氨酸在制备防治放射性肺损伤药物中的应用
Colly et al. Effect of the interval between high dose 1-β-D-arabinofuranosylcytosine injections on leukemic cell load, intestinal toxicity, and normal hematopoietic stem cells in a rat model for acute myelogenous leukemia
Sonnet et al. The treatment of trichinosis with mebendazole
WO1991004047A1 (en) Synergistic effect of human recombinant interferon-beta on halogenated pyrimidines
Cravey et al. The distribution of morphine in man following chronic intravenous administration
SU923547A1 (ru) Способ лечени бронхиальной астмы
US4296124A (en) Pharmaceutical methods
SU1367975A1 (ru) Способ лечени деструктивного туберкулеза легких
RU2678821C1 (ru) Фармацевтическая композиция для лечения заболеваний полости рта с противовоспалительным и антибактериальным действиями
CN119385999A (zh) 壬二酸在制备防治放射性肺损伤药物中的应用

Legal Events

Date Code Title Description
PA0109 Patent application

St.27 status event code: A-0-1-A10-A12-nap-PA0109

R17-X000 Change to representative recorded

St.27 status event code: A-3-3-R10-R17-oth-X000

A201 Request for examination
P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

G160 Decision to publish patent application
PG1605 Publication of application before grant of patent

St.27 status event code: A-2-2-Q10-Q13-nap-PG1605

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

St.27 status event code: A-1-2-D10-D22-exm-PE0701

GRNT Written decision to grant
PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U11-oth-PR1002

Fee payment year number: 1

LAPS Lapse due to unpaid annual fee
PC1903 Unpaid annual fee

St.27 status event code: A-4-4-U10-U13-oth-PC1903

Not in force date: 19910313

Payment event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

PC1903 Unpaid annual fee

St.27 status event code: N-4-6-H10-H13-oth-PC1903

Ip right cessation event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

Not in force date: 19910313